Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats

J Neurosci Res. 2006 Sep;84(4):832-40. doi: 10.1002/jnr.20977.

Abstract

Calpains and cathepsins are two families of proteases that play an important role in ischemic cell death. In this study, we investigated the effect of E64d, a mu-calpain and cathepsin B inhibitor, in the prevention of neuronal and endothelial apoptotic cell death after focal cerebral ischemia in rats. Rats underwent 2 hr of transient focal ischemia from middle cerebral artery occlusion (MCAO) and were sacrificed 24 hr later. E64d (5 mg/ kg intraperitoneally) was administered 30 min before MCAO. Assessment included neurological function, infarction volume, brain water content, blood-brain barrier permeability, histology, and immunohistochemistry. The E64d-treated rats had significant brain protection against ischemic damage. We observed a reduction of infarction volume, brain edema, and improved neurological scores in E64d-treated rats compared with the nontreated control. Furthermore, there was a remarkable reduction in both proteases and caspase-3 activation and apoptotic changes in both neurons and endothelial cells in E64d-treated rats. These results suggest that E64d protects the brain against ischemic/reperfusion injury by attenuating neuronal and endothelial apoptosis.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Analysis of Variance
  • Animals
  • Apoptosis / drug effects*
  • Brain Edema / drug therapy
  • Brain Infarction / etiology
  • Brain Infarction / pathology
  • Brain Infarction / prevention & control
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control*
  • Calpain / metabolism
  • Caspase 3
  • Caspases / metabolism
  • Cathepsins / metabolism
  • Endothelium, Vascular / drug effects*
  • Functional Laterality / physiology
  • Gene Expression / drug effects
  • Immunohistochemistry / methods
  • In Situ Nick-End Labeling / methods
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / pathology
  • Leucine / analogs & derivatives*
  • Leucine / therapeutic use
  • Male
  • Neurologic Examination / methods
  • Neurons / drug effects*
  • Neuroprotective Agents / therapeutic use*
  • Phosphopyruvate Hydratase / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Tetrazolium Salts

Substances

  • Neuroprotective Agents
  • Tetrazolium Salts
  • triphenyltetrazolium
  • Cathepsins
  • Calpain
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • mu-calpain
  • Phosphopyruvate Hydratase
  • Leucine
  • aloxistatin